New Personalized Medicine Model for Medication Management.

Area of Science:

• Pharmacology
• Genomics
• Personalized Medicine

Background:

• Traditional pharmacokinetics and pharmacodynamics do not fully capture cellular drug responses.
• Drug efficacy and toxicity are influenced by genetics, microbiomics, and various omics alterations.
• The oral medication process involves pharmacokinetics, oral and gut microbiomics, and pharmacodynamics.

Purpose of the Study:

• To introduce an integrative Personalized Medicine Model for comprehensive medication management.
• To demonstrate the clinical utility of this model using SSRIs and statins as examples.
• To highlight the need for multi-omics data integration for improved patient outcomes.

Main Methods:

• Review of traditional and emerging approaches in drug response assessment.
• Integration of pharmacogenetics, pharmacogenomics, and multi-omics data (epigenetic, transcriptomic, proteomic, metabolomic).
• Development of a personalized medicine model for drug selection and dosing.

Main Results:

• The proposed model can guide individualized drug selection and dosing, reducing trial-and-error.
• Application cases with SSRIs and statins show potential for improved patient safety and outcomes.
• Integration of multi-omics data is crucial for decision support and actionable recommendations.

Conclusions:

• An integrative personalized medicine model utilizing multi-omics data offers a pathway to optimize medication management.
• Further research is required for full implementation in drug development, clinical care, and healthcare systems.
• Successful integration necessitates robust IT infrastructure and stakeholder collaboration.